Analytical Data
-
基因名
PRAC
- Application
-
别名
PRAC;C17orf92;PRAC;Small nuclear Protein PRAC1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96KF2
-
表达区间
1-57aa
-
氨基酸序列
MLCAHFSDQG PAHLTTSKSA FLSNKKTSTL KHLLGETRSD GSACNSGISG GRGRKIP
-
分子量
5.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of PRAC (Protein Receptor-Associated Complex) recombinant proteins has gained significant attention in recent years due to their crucial role in various biological processes and therapeutic applications. PRACs are involved in mediating cellular responses to external stimuli, playing vital roles in signaling pathways that regulate cell growth, differentiation, and apoptosis. The ability to produce recombinant forms of these proteins allows researchers to dissect their functions and mechanisms in detail, thus contributing to our understanding of complex cellular interactions. Moreover, recombinant PRACs serve as valuable tools in drug discovery and development, providing insights into potential therapeutic targets for diseases such as cancer, cardiovascular disorders, and neurological conditions. Advances in molecular biology techniques have facilitated the cloning, expression, and purification of PRACs, enabling high-throughput production and functional characterization. As a result, the investigation of PRAC recombinant proteins is not only essential for elucidating fundamental biological questions but also for the advancement of clinical therapies and biotechnological applications, underscoring the importance of ongoing research in this field.












